Home › Scleroderma › Arizona › Tucson
Scleroderma clinical trials in Tucson, AZ
3 studies for Scleroderma are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Tucson
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Tucson, Tucson
A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1
- Research Site, Tucson
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Chicago, IL10 studies
- Ann Arbor, MI10 studies
- Houston, TX9 studies
- Durham, NC7 studies
- Boston, MA7 studies
- Los Angeles, CA7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- New Orleans, LA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
Other studies in Tucson
- Breast Cancer20 studies
- Non-Small Cell Lung Cancer17 studies
- Obesity17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)13 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Heart Failure10 studies
- High Blood Pressure10 studies
- Type 2 Diabetes10 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.